IRulya Therapeutics Inc.
IRulya Therapeutics Inc. scores highest on Torque (57) and lowest on Price (0). Its PosiPenta is 27.52 out of 100, weaker than most similar companies.
On the Penta Grid this week, IRulya Therapeutics Inc. is Grid #790 of 837 in the Healthcare sector in United States, and Grid #3,731 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| IRulya Therapeutics Inc. | 27.52 | 0 | 39 | 13 | 57 | 28 |
| DarioHealth Corp. | 36.51 | 41 | 44 | 13 | 35 | 50 |
| CervoMed Inc. | 38.23 | 33 | 42 | 20 | 58 | 38 |
| Celularity Inc. | 51.08 | 0 | 48 | 54 | 96 | 57 |
| Impact BioMedical Inc. | 61.00 | 75 | 96 | 20 | 72 | 42 |
| QT Imaging Holdings, Inc. | 23.32 | 4 | 41 | 7 | 2 | 63 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.14 |
| P/B ratio | -0.92 |
EEarnings
| Trailing EPS | ₹-21565.65 |
| Forward EPS | ₹-443.58 |
NNitro
| Price | 3033.72 |
| 52-week high | 86190.61 |
| 52-week low | 1430.20 |
| Fall from 52-week high | 96.5% |
TTorque
| Return on equity (ROE) | -153.84% |
| Debt-to-equity | -0.52 |
AAnchor
| Beta (price swings) | 1.33 |
| Market cap | ₹308 Cr |
| Insider holding | 0.27% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is IRulya Therapeutics Inc.'s PosiPenta score?
IRulya Therapeutics Inc.'s PosiPenta is 27.52 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does IRulya Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, IRulya Therapeutics Inc. is Grid #790 of 837 in the Healthcare sector in United States, and Grid #3,731 of 4,000 in United States.
Which PosiPenta pillar is strongest for IRulya Therapeutics Inc.?
Torque (durability), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for IRulya Therapeutics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.